Institute researchers are involved in a number of clinical trials that show promise for the translation of stem cell research from bench to bedside.
Below is a list of the current clinical trials underway from the researchers at CSCI.
If you would like to find out more about clinical trials, please contact us at enquiries@stemcells.cam.ac.uk
|
Trial Lead |
Topic | Description | More details |
|
Parkinson's disease |
Effects of OXB-102 in patients with bilateral, idiopathic Parkinson's Disease. | NCT03720418 | |
|
Parkinson's disease |
TRANSEURO open label transplant study in Parkinson's Disease. | NCT01898390 | |
|
Blood components |
RESTORE - recovery and survival of stem cell originated red cells - currently pending approval from the Health Research Authority. | RESTORE | |
|
Haematologic malignancies |
Dose escalation study to investigate the clinical activity of BET inhibitors in subjects with relapsed, refractory hematologic malignancies | NCT01943851 | |
| Osteoarthritis | Evaluation the efficacy of adipose derived mesenchymal stromal cells in patients with knee osteoarthritis. | NCT02838069 | |
| Myeloproliferative neoplasms | Redeployment of tamoxifen to modulate the bone marrow niche and treat myeloproliferative neoplasms | 2015-05497-38 | |
| Connatal Pelizaeus-Merzbacher Disease | Five-year long term follow-up study of a neural stem cell therapy trial for Connatal Pelizaeus-Merzbacher Disease | NCT01005004 & NCT01391637 |